top of page

December 2018 // Funding

Synendos Therapeutics won Venture Kick Stage I and was awarded with CHF 10’000. This funding contributes the company to structure business ideas, target initial customers and strategic partners to build a solid business case.

Recent Posts

See All

Synendos Series A Extension Synendos Therapeutics is thrilled to announce an extension to the Series A financing with the addition of Ysios Capital to its syndicate of European investors. Ysios Capita

Synendos and Prof. Jürg Gertsch received an Innosuisse Innovation Grant (total value of CHF 950’000).

bottom of page